Inventor · San Diego, CA, US

Brett Ullman

26Patents
7h-index
38Co-inventors
69Inventor score

Filing activity: Oct 22, 1998 → Apr 22, 2022

Most-cited inventions

PatentTitleAreaCited byStatus
US9567327B2 Imidazo[1,2-a]pyridine derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto Chemistry; Metallurgy 53 Active
US6242422A (Substituted)Acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases Chemistry; Metallurgy 46 Expired
US8580841B2 Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders Emerging Cross-Sectional Technologies 17 Active
US9434692B2 Pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto Chemistry; Metallurgy 16 Active
US9732039B2 Pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto Chemistry; Metallurgy 15 Active
US9126932B2 Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders Emerging Cross-Sectional Technologies 15 Active
US9522133B2 Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders Emerging Cross-Sectional Technologies 9 Active
US8940891B2 Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto Chemistry; Metallurgy 6 Active
US10058549B2 Imidazo[1,2-α]pyridine derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto Chemistry; Metallurgy 4 Active
US9012478B2 Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto Chemistry; Metallurgy 4 Active
US10479797B2 Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of disorders related thereto Human Necessities 3 Active
US9663500B2 Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto Chemistry; Metallurgy 3 Active
US10214518B2 Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto Chemistry; Metallurgy 2 Active
US10662200B2 Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of disorders related thereto Human Necessities 2 Active
US11098034B2 Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto Chemistry; Metallurgy 1 Active
US11339172B2 Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of heart failure and disorders related thereto Chemistry; Metallurgy 1 Active
US10793529B2 Substituted pyridazines and 1,2,4-triazines as prostacyclin receptor modulators Chemistry; Metallurgy 1 Active
US10138210B2 Substituted pyridazines as prostacyclin receptor modulators Chemistry; Metallurgy 1 Active
US10689372B2 Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto Chemistry; Metallurgy 1 Active
US10927123B2 Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of disorders related thereto Human Necessities 1 Active
US11987588B2 Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of heart failure and disorders related thereto Chemistry; Metallurgy 0 Active
US10351531B2 Pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto Chemistry; Metallurgy 0 Active
US7157430B2 (Substituted)acyl dipeptidyl inhibitors of the ICE/CED-3 family of cysteine proteases Chemistry; Metallurgy 0 Expired
US11560386B2 Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of disorders related thereto Human Necessities 0 Active
US11066416B2 Rapafucin derivative compounds and methods of use thereof Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.